Keywords: Glycosite Analysis, Glycoproteomics, Mass Spectrometry, Glycosite, Enrichment, De-glycosylation, Intact glycopeptides, Quantification, Collision-inducced dissociation (CID), Electron transfer dissociation (ETD), Multistage tandem MS (MSn), Post-translational modifications, Covalent modifications, Numerous Cellular Processes, Glycoproteins, Post Proteomic er, N-linked glycans, Sugar structure elucidation, Micro-heterogeneity, Coexisting non-glycoproteins/peptides, Mammalian lectins, Galectins, selectins, Chemo-enzymatic labeling, De-Glycosylation Methods, O-GlcNAc modifcation, Beta-elemination, Michael addition, Dithiothreitol, Multiple lectin-mediated, Hydrazide chemistry, Non-redundant glycoproteins, Subproteome, O-GlcNAc Site, Mucin-type O-Glycosites, Electron Capture Dissociation (ECD), Infrared multiphoton dissociation (IRMPD), ETD/ECD Assisted Glycosite, Labeling based Quantification, Label-free Quantification, Immuno-enriched, BAP= Biotin pentylamine, ESI=Electrospray ionization, CDK=Climatic droplet keratopathy, CSC=Cell surface capturing, CRC=Colorectal cancer
Current Proteomics
Title: Editorial:[Special Issue: Post-Translational Proteomics and its Application (Guest Editor: Qing-Yu He)]
Volume: 7 Issue: 3
Author(s): Qing-Yu He
Affiliation:
Keywords: Glycosite Analysis, Glycoproteomics, Mass Spectrometry, Glycosite, Enrichment, De-glycosylation, Intact glycopeptides, Quantification, Collision-inducced dissociation (CID), Electron transfer dissociation (ETD), Multistage tandem MS (MSn), Post-translational modifications, Covalent modifications, Numerous Cellular Processes, Glycoproteins, Post Proteomic er, N-linked glycans, Sugar structure elucidation, Micro-heterogeneity, Coexisting non-glycoproteins/peptides, Mammalian lectins, Galectins, selectins, Chemo-enzymatic labeling, De-Glycosylation Methods, O-GlcNAc modifcation, Beta-elemination, Michael addition, Dithiothreitol, Multiple lectin-mediated, Hydrazide chemistry, Non-redundant glycoproteins, Subproteome, O-GlcNAc Site, Mucin-type O-Glycosites, Electron Capture Dissociation (ECD), Infrared multiphoton dissociation (IRMPD), ETD/ECD Assisted Glycosite, Labeling based Quantification, Label-free Quantification, Immuno-enriched, BAP= Biotin pentylamine, ESI=Electrospray ionization, CDK=Climatic droplet keratopathy, CSC=Cell surface capturing, CRC=Colorectal cancer
Export Options
About this article
Cite this article as:
He Qing-Yu, Editorial:[Special Issue: Post-Translational Proteomics and its Application (Guest Editor: Qing-Yu He)], Current Proteomics 2010; 7 (3) . https://dx.doi.org/10.2174/157016410792928170
DOI https://dx.doi.org/10.2174/157016410792928170 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytokines in Colitis-Associated Cancer: Potential Drug Targets?
Inflammation & Allergy - Drug Targets (Discontinued) Homocysteine and Folate Therapy in Dialysis Patients
Letters in Drug Design & Discovery The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target
Current Medicinal Chemistry Subject Index to Volume 9
Current Pharmaceutical Design Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities
Current Drug Targets Involvement of Cysteine Proteases in Cancer
Current Medicinal Chemistry Anti-Cancer Compounds from Terrestrial and Marine Resources -In silico and Experimental Studies
Current Computer-Aided Drug Design Inhibitory Smad7: Emerging Roles in Health and Disease
Current Molecular Pharmacology Evaluation of microRNA Stability in Plasma and Serum from Healthy Dogs
MicroRNA Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies
Current Molecular Medicine Prognostic and Predictive Markers in Colorectal Cancer – The Role of New Genomic Technologies
Current Pharmacogenomics Lessons Learned from the Irinotecan Metabolic Pathway
Current Medicinal Chemistry Cellomics as Integrative Omics for Cancer
Current Proteomics Carbonic Anhydrase Inhibitors and the Management of Cancer
Current Topics in Medicinal Chemistry Extraction of Triacylglycerols and Fatty Acids Using Supercritical Fluids - Review
Current Analytical Chemistry Is Effective and Safe a Radiochemotherapy Approach in Elderly Cancer Patients? A Review
Anti-Cancer Agents in Medicinal Chemistry Downstream Carcinogenesis Signaling Pathways by Green Tea Polyphenols: A Translational Perspective of Chemoprevention and Treatment for Cancers
Current Drug Metabolism Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges
Current Vascular Pharmacology Current Strategies for the Treatment of Ulcerative Colitis
Recent Patents on Inflammation & Allergy Drug Discovery Emergence of Functionalized Nanomedicines in Cancer Chemotherapy: Recent Advancements, Current Challenges and Toxicity Considerations
Recent Patents on Nanomedicine